Marc S. Williams
Marc S. Williams
Professor and Director Emeritus, Genomic Medicine Institute, Geisinger
Verified email at - Homepage
Cited by
Cited by
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
RC Green, JS Berg, WW Grody, SS Kalia, BR Korf, CL Martin, AL McGuire, ...
Genetics in medicine 15 (7), 565-574, 2013
Implementing genomic medicine in the clinic: the future is here
TA Manolio, RL Chisholm, B Ozenberger, DM Roden, MS Williams, ...
Genetics in Medicine 15 (4), 258-267, 2013
CHARGE association: an update and review for the primary pediatrician
KD Blake, SLH Davenport, BD Hall, MA Hefner, RA Pagon, MS Williams, ...
Clinical pediatrics 37 (3), 159-173, 1998
The electronic medical records and genomics (eMERGE) network: past, present, and future
O Gottesman, H Kuivaniemi, G Tromp, WA Faucett, R Li, TA Manolio, ...
Genetics in Medicine 15 (10), 761-771, 2013
American College of Medical Genetics and Genomics. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
RC Green, JS Berg, WW Grody, SS Kalia, BR Korf, CL Martin, AL McGuire, ...
Genet Med 15 (7), 565-574, 2013
Return of genomic results to research participants: the floor, the ceiling, and the choices in between
GP Jarvik, LM Amendola, JS Berg, K Brothers, EW Clayton, W Chung, ...
The American Journal of Human Genetics 94 (6), 818-826, 2014
Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process
K E Caudle, T E Klein, J M Hoffman, D J Muller, M Whirl-Carrillo, L Gong, ...
Current drug metabolism 15 (2), 209-217, 2014
Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)
KE Caudle, HM Dunnenberger, RR Freimuth, JF Peterson, JD Burlison, ...
Genetics in Medicine 19 (2), 215-223, 2017
Population-based family history–specific risks for colorectal cancer: a constellation approach
DP Taylor, RW Burt, MS Williams, PJ Haug, LA Cannon–Albright
Gastroenterology 138 (3), 877-885, 2010
Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin
DA Flockhart, D O'Kane, MS Williams, MS Watson, B Gage, R Gandolfi, ...
Genetics in Medicine 10 (2), 139-150, 2008
Design and anticipated outcomes of the eMERGE‐PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems
LJ Rasmussen‐Torvik, SC Stallings, AS Gordon, B Almoguera, ...
Clinical Pharmacology & Therapeutics 96 (4), 482-489, 2014
Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history
M Deneau, MK Jensen, J Holmen, MS Williams, LS Book, SL Guthery
Hepatology 58 (4), 1392-1400, 2013
Association of arrhythmia-related genetic variants with phenotypes documented in electronic medical records
SL Van Driest, QS Wells, S Stallings, WS Bush, A Gordon, DA Nickerson, ...
Jama 315 (1), 47-57, 2016
Mutations in PIEZO2 cause Gordon syndrome, Marden-Walker syndrome, and distal arthrogryposis type 5
MJ McMillin, AE Beck, JX Chong, KM Shively, KJ Buckingham, ...
The American Journal of Human Genetics 94 (5), 734-744, 2014
Genetic variation among 82 pharmacogenes: the PGRNseq data from the eMERGE network
WS Bush, DR Crosslin, A Owusu‐Obeng, J Wallace, B Almoguera, ...
Clinical Pharmacology & Therapeutics 100 (2), 160-169, 2016
Exome sequencing–based screening for BRCA1/2 expected pathogenic variants among adult biobank participants
K Manickam, AH Buchanan, MLB Schwartz, MLG Hallquist, JL Williams, ...
JAMA Network Open 1 (5), e182140-e182140, 2018
Global implementation of genomic medicine: we are not alone
TA Manolio, M Abramowicz, F Al-Mulla, W Anderson, R Balling, ...
Science translational medicine 7 (290), 290ps13-290ps13, 2015
Family history and the natural history of colorectal cancer: systematic review
NB Henrikson, EM Webber, KA Goddard, A Scrol, M Piper, MS Williams, ...
Genetics in medicine 17 (9), 702-712, 2015
A policy model to evaluate the benefits, risks and costs of warfarin pharmacogenomic testing
LM Meckley, JM Gudgeon, JL Anderson, MS Williams, DL Veenstra
Pharmacoeconomics 28 (1), 61-74, 2010
Further delineation of Kabuki syndrome in 48 well‐defined new individuals
L Armstrong, AAE Moneim, K Aleck, DJ Aughton, C Baumann, ...
American Journal of Medical Genetics Part A 132 (3), 265-272, 2005
The system can't perform the operation now. Try again later.
Articles 1–20